Literature DB >> 21493086

Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients.

Ross C McLean1, Andrew H Briggs, Rachel Slack, Vipin Zamvar, Geoffrey A Berg, Hussein El-Shafei, Keith G Oldroyd, Jill P Pell.   

Abstract

OBJECTIVE: Because of increasing life expectancy, more patients require valve replacement for aortic stenosis. We aimed to determine perioperative and long-term outcomes, the factors associated with these and whether they have changed over time.
METHODS: We undertook a retrospective cohort study of all 4124 patients, who underwent isolated, primary aortic valve replacement in Scotland between April 1996 and March 2009 inclusive.
RESULTS: Annual operations increased by 68%, from 261 to 439. The overall risk of dying within 30 days, 5 years and 10 years was 3.4%, 19.9% and 38.5%, respectively. Over 10 years' follow-up, 4.4% underwent further valve surgery, 7.9% suffered a stroke and 5.3% a myocardial infarction. Age, renal impairment and urgency were predictors of both perioperative and long-term death. Perioperative death was associated with left-ventricular impairment and long-term death with respiratory disease, diabetes and deprivation. Over the 13 years, there was an increase in median age (from 66 to 69 years, p < 0.001), diabetes (from 1.9% to 12.6%, p < 0.001), hypertension (from 26.4% to 56.1%, p < 0.001), cerebrovascular disease (from 3.7% to 9.8%, p < 0.001), respiratory disease (from 6.6% to 9.7%, p = 0.020) and previous myocardial infarction (from 0.6% to 5.8%, p < 0.001), but the risk of perioperative death fell from 6.5% to 3.1% (odds ratio (OR) 0.87, 95% confidence interval (CI) 0.83, 0.92, p < 0.001) per year.
CONCLUSIONS: Patients undergoing aortic valve replacement have a poor risk profile. Over time, their numbers, age and co-morbidity have increased. In spite of these, there has been a significant reduction in the risk of perioperative death.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21493086     DOI: 10.1016/j.ejcts.2011.01.088

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Long-Term Post-CABG Survival: Performance of Clinical Risk Models Versus Actuarial Predictions.

Authors:  Brendan M Carr; Jamie Romeiser; Joyce Ruan; Sandeep Gupta; Frank C Seifert; Wei Zhu; A Laurie Shroyer
Journal:  J Card Surg       Date:  2015-11-05       Impact factor: 1.620

2.  Minimally Invasive Video-assisted Mitral Valve Replacement with a Right Chest Small Incision in Patients Aged Over 65 Years.

Authors:  Qiang Chen; Ling-Li Yu; Qi-Liang Zhang; Hua Cao; Liang-Wan Chen; Zhong-Yao Huang
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

Review 3.  Bioprosthetic Aortic Valve Replacement in <50 Years Old Patients - Where is the Evidence?

Authors:  Amer Harky; Michael Man Yuen Suen; Chris Ho Ming Wong; Abdul Rahman Maaliki; Mohamad Bashir
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

4.  Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies.

Authors:  Farid Foroutan; Gordon H Guyatt; Kathleen O'Brien; Eva Bain; Madeleine Stein; Sai Bhagra; Daegan Sit; Rakhshan Kamran; Yaping Chang; Tahira Devji; Hassan Mir; Veena Manja; Toni Schofield; Reed A Siemieniuk; Thomas Agoritsas; Rodrigo Bagur; Catherine M Otto; Per O Vandvik
Journal:  BMJ       Date:  2016-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.